Key Insights

Highlights

Success Rate

82% trial completion

Published Results

38 trials with published results (13%)

Research Maturity

78 completed trials (26% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

5.7%

17 terminated out of 298 trials

Success Rate

82.1%

-4.4% vs benchmark

Late-Stage Pipeline

6%

18 trials in Phase 3/4

Results Transparency

49%

38 of 78 completed with results

Key Signals

38 with results82% success17 terminated

Data Visualizations

Phase Distribution

216Total
Not Applicable (115)
Early P 1 (10)
P 1 (36)
P 2 (37)
P 3 (16)
P 4 (2)

Trial Status

Recruiting98
Completed78
Active Not Recruiting67
Terminated17
Not Yet Recruiting16
Withdrawn11

Trial Success Rate

82.1%

Benchmark: 86.5%

Based on 78 completed trials

Clinical Trials (298)

Showing 20 of 20 trials
NCT05554367Phase 2Active Not Recruiting

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

NCT07259304Active Not Recruiting

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

NCT03816345Phase 1Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT06126276Phase 2Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

NCT04387656Active Not Recruiting

NCI COVID-19 in Cancer Patients, NCCAPS Study

NCT02453620Phase 1Active Not Recruiting

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

NCT07737314Not ApplicableNot Yet Recruiting

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

NCT03168737Phase 1Active Not Recruiting

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

NCT06136897Phase 2Active Not RecruitingPrimary

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

NCT07285044Phase 2Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

NCT06569316Not ApplicableRecruiting

Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)

NCT07733141Not ApplicableNot Yet Recruiting

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

NCT06565260Not ApplicableRecruiting

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

NCT02962661Phase 1Recruiting

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

NCT06206863Not ApplicableRecruiting

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

NCT05411523Recruiting

Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

NCT07723495Not ApplicableNot Yet RecruitingPrimary

Symptom Management to Improve Completion of Patient-reported Outcome Measures

NCT07729384Not ApplicableNot Yet Recruiting

A Study of Strengthening Teen Brain Resilience Using Music During Cancer Treatment

NCT03223753Phase 3Completed

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

NCT07606287Not ApplicableNot Yet Recruiting

Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital

Scroll to load more

Research Network

Activity Timeline